Case number 1:22-cv-00726
Novartis Pharmaceuticals Corporation v. Biocon Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 3, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Limited waiver sent on 7/6/2022, answer due 9/6/2022. (Silver, Daniel) |
| Aug 3, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Pharma, Inc. waiver sent on 7/6/2022, answer due 9/6/2022. (Silver, Daniel) |
| Aug 3, 2022 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Pharma Limited waiver sent on 7/6/2022, answer due 9/6/2022. (Silver, Daniel) |
| Jul 25, 2022 | 7 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Chart for U.S. Patent No. 11,058,667 and Plaintiff's First Supplemental Infringement Chart for U.S. Patent No. 11,096,918 against Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 14, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas N. Kallas and Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 9, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher E. Loh for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jun 9, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jared L. Stringham for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 8, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [6] MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham, filed by Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 6/8/2022. (nms) |
| Jun 8, 2022 | 6 | Main Document (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham)(Silver, Daniel) |
| Jun 8, 2022 | 6 | Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, a (4) |
| Jun 2, 2022 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
| Jun 2, 2022 | 1 | Main Document (14) Docket Text: COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-3887457.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
| Jun 2, 2022 | 1 | Exhibit A (16) |
| Jun 2, 2022 | 1 | Civil Cover Sheet (3) |
| Jun 2, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Jun 2, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/18/2022. Date of Expiration of Patent: 5/9/2036.Thirty Month Stay Deadline: 7/7/2023. (apk) |
| Jun 2, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,667. (apk) |
| Jun 2, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk) |
| Jun 2, 2022 | 1 | Complaint* (1) |
